Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)

Title				Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)

Author				Löwenberg, B. Suciu, S. Archimbaud, E. Ossenkoppele, G. Verhoef, G.E.G. Vellenga, E. Wijermans, P. Berneman, Z. Dekker, A.W. Stryckmans, P. Schouten, H. Jehn, U. Muus, P. Sonneveld, P. Dardenne, M. Zittoun, R.

Language				English

Source (journal)				Blood / American Society of Hematology. - New York, N.Y.

Publication				New York, N.Y. : 1997

ISSN				0006-4971

Volume/pages				90 :8 (1997) , p. 2952-2961

Faculty/Department				Faculty of Medicine and Health Sciences

Publication type				A1 Journal article

Affiliation				Publications with a UAntwerp address

Identifier

Creation

08.10.2008

Last edited

04.03.2024

To cite this reference